Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Pliant Therapeutics (PLRX) Equity Ratio (2019 - 2026)

Pliant Therapeutics has reported Equity Ratio over the past 8 years, most recently at 0.82 for Q1 2026.

  • Quarterly Equity Ratio rose 9.3% to 0.82 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.82 through Mar 2026, up 9.3% year-over-year, with the annual reading at 0.8 for FY2025, 5.03% up from the prior year.
  • Equity Ratio was 0.82 for Q1 2026 at Pliant Therapeutics, up from 0.8 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.94 in Q1 2023 and troughed at 0.72 in Q3 2025.
  • The 5-year median for Equity Ratio is 0.82 (2026), against an average of 0.84.
  • Year-over-year, Equity Ratio increased 15.83% in 2023 and then fell 17.16% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.89 in 2022, then rose by 3.47% to 0.92 in 2023, then dropped by 17.16% to 0.77 in 2024, then rose by 5.03% to 0.8 in 2025, then increased by 1.33% to 0.82 in 2026.
  • Per Business Quant, the three most recent readings for PLRX's Equity Ratio are 0.82 (Q1 2026), 0.8 (Q4 2025), and 0.72 (Q3 2025).